|
|
|
Case Western Reserve University
Institutional Biosafety Committee (IBC)
Overview and Purpose of the Case IBC
Case Western Reserve University’s IBC is charged with the responsibility for the oversight and approval of research activities involving recombinant DNA that take place at Case, MetroHealth Medical Center, Louis Stokes Veteran’s Administration and University Hospitals Case Medical Center.
- Examples of rDNA research include, but are not limited to, the production of transgenic animals, gene therapy or vaccination studies where the structure of the virus is genetically manipulated in humans or animals, cloning using animals or human pathogens and the use of rDNA, pathogenic or other infectious agents and recombinant viral vectors.
Since Case receives funding from NIH grants, all recombinant DNA research conducted at the aforementioned institutions must comply with NIH Guidelines and the Case IBC Policies.
Important Safety and Regulatory Links:
NIH’s Office of Biotechnology Activities
CDC
Case IBC Policies
NIH’s Guidance on Biosafety Conditions for Lentiviral Vectors
|
| |
|
| |
|
| |
|
|
